Abbvie Contract MFG

Learn how potent drug contract manufacturing supports safe, contained production of high-potency medicines, including solid dose manufacturing and compliance controls. Potent Drug Contract Manufacturing: What Every Sponsor Needs to Know Before Choosing a CDMO? Potent drug contract manufacturing is a specialised pharmaceutical service in which a contract development and manufacturing organisation (CDMO) produces highly active drug substances and finished dose forms — typically defined by an Occupational Exposure Limit (OEL) at or below 10 µg/m³ — under engineered containment conditions. These conditions include closed RABS, isolators, and continuous liner technology to protect workers while maintaining product integrity and full regulatory compliance. As oncology pipelines swell and precision medicine gains momentum, sponsors who understand what separates a genuinely capable potent CDMO from a standard manufacturer will be far better positioned to protect both their patients and their p...

  Explore proprietary hot melt extrusion and how it enhances drug formulation, improving solubility, consistency, and performance in pharmaceutical products. Proprietary Hot Melt Extrusion: The Manufacturing Edge That Changes Everything for Hard-to-Formulate Molecules Roughly 40% of approved drugs — and an estimated 90% of compounds currently in development pipelines — suffer from poor water solubility. That single physicochemical flaw is responsible for more late-stage formulation failures than almost any other factor. Fixing it is not merely a technical exercise; it is often the difference between a molecule that reaches patients and one that never leaves the lab. According to the FDA's Biopharmaceutics Classification System framework , BCS Class II and IV drugs require sophisticated enabling technologies to achieve adequate oral bioavailability. Hot melt extrusion is one of the most powerful of those technologies — and when the process is proprietary, the advantages compound. Th...

Learn what custom API manufacturing is, how custom active pharmaceutical ingredients are developed, and why they are critical for drug quality and scale. What Is a Custom API And Why Does It Define the Success of Your Drug Programme? There is a moment in almost every drug development programme when the path forward depends on a single question: can you actually make this molecule at scale? The chemistry might be elegant. The clinical hypothesis might be sound. But if the synthesis cannot be reliably reproduced at the quantities required for Phase II or commercial supply, everything downstream stalls. That is where a custom api partnership becomes less of a commercial convenience and more of a scientific necessity. Custom active pharmaceutical ingredients — APIs developed to a sponsor's unique specification rather than purchased off a catalogue — represent some of the most technically demanding work in pharmaceutical manufacturing. They involve proprietary synthesis routes, complex...